Sale!

Tafinlar 75mg 120 Capsule

1,988.57$

Tablets per box: 120;
Manufacturer: Novartis

Add to Wishlist
Add to Wishlist
Category:

Description

MG Medicals, Quality Assurance

CompositionDabrafenib 75mg
SimilarityDabrafenib 75mg
UsageThere is no data.
StorageRoom Temperature
CautionThere is no data.

MG Medicals, Briefing of Tafinlar 75mg 120 Capsule

Uses of Tafinlar 75mg 120 CapsuleUses of Tafinlar 75mg 120 Capsule
melanoma (skin cancer) that cannot be treated with surgery or has spread to other parts of the body, or to prevent melanoma from coming back after surgery;non-small cell lung cancer that has spread to other parts of the body; or advanced or metastatic thyroid cancer that has spread and for which there are no other treatment options.
Tafinlar 75mg 120 Capsule side reactionsTafinlar 75mg 120 Capsule side reactions
acne-like skin condition, constipation, cough, decreased appetite, diarrhea, dry mouth, dry skin hair loss or thinning, headache, increased sweating, lack of energy, mouth sores or ulcers, nausea, nail changes, rash, stomach pain, thickened skin, vomiting, weakness
How to take Tafinlar 75mg 120 CapsuleHow to take Tafinlar 75mg 120 Capsule
Take TAFINLAR at doses approximately 12 hours apart. ​Take TAFINLAR at least 1 hour before or 2 hours after a meal. ​Do not take a missed dose of TAFINLAR within 6 hours of the next dose of TAFINLAR. ​Do not open, crush, or break TAFINLAR capsules.
How Tafinlar 75mg 120 Capsule worksHow Tafinlar 75mg 120 Capsule works
Dabrafenib belongs to the group of cancer-fighting medications known as antineoplastics, and specifically to the family of medications called protein kinase inhibitors. It is used to treat a specific type of melanoma (skin cancer) that cannot be surgically removed or has metastasized (spread to other parts of the body).

MG Medicals, More Suggestion

Suggestion for Tafinlar 75mg 120 Capsule

  • Bleeding: People taking the combination of trametinib and dabrafenib may be more likely to make it difficult to stop cuts from bleeding. If you notice any signs of bleeding, such as frequent nosebleeds, unexplained bruising, or black and tarry stools, notify your doctor as soon as possible
  • Blood clots: People who take dabrafenib in combination with trametinib may be at increased risk of developing blood clots, causing reduction of blood flow to organs or the extremities.
  • If you experience symptoms such as sharp pain and swelling in the leg, difficulty breathing, chest pain, blurred vision or difficulty speaking, contact your doctor immediately.
  • Diabetes: Dabrafenib may cause an increase in blood sugar levels and glucose tolerance may change. People with diabetes may find it necessary to monitor their blood sugar more frequently while using this medication.
  • Eye inflammation: Dabrafenib may cause eye inflammation. If you experience eye pain, changes in your vision or eye pain when you are exposed to light, contact your doctor as soon as possible

MG Medicals, Tips & Warnings

alcohol
Alcohol
There is no available data.
pregnancy
Pregnancy
There are no data from the use of dabrafenib in pregnant women. Animal studies have shown reproductive toxicity and embryo-foetal developmental toxicities, including teratogenic effects
lactation
Lactation
It is not known whether dabrafenib is excreted in human milk. Because many medicinal products are
excreted in human milk, a risk to the breast-feeding child cannot be excluded. A decision should be
made whether to discontinue breast-feeding or discontinue dabrafenib, taking into account the benefit
of breast-feeding for the child and the benefit of therapy for the woman.
driving
Driving
There is no available data.
kidney
Kidney
No dose adjustment is required for patients with mild or moderate renal impairment. There are no clinical data in subjects with severe renal impairment and the potential need for dose adjustment cannot be determined.
liver
Liver
No dose adjustment is required for patients with mild hepatic impairment. There are no clinical data in subjects with moderate to severe hepatic impairment and the potential need for dose adjustment cannot be determined.

MG Medicals, If miss a dose

If a dose of dabrafenib is missed, it should not be taken if it is less than 6 hours until the next dose.

Disclaimer

The site and the information of MG Medicals (mgmedicals.com) are ONLY for reference purposes, and mgmedicals.com or MG Medicals or MG Medicals Pharmacy cannot be a replacement of professional medical advice, diagnosis, or treatment. MG Medicals request all visitors to obtain the advice of a physician or any qualified health provider with any questions they may have regarding a medical condition. Any prescription drugs, it’s only be sold with the approval of qualified doctors, specialists, or pharmacists.
Scroll to top